Upregulation of LINC00857 improved growth, invasion and migration abilities of PAAD cells by modulation of miR-340-5p/TGFA, affording potential targets and biomarkers for the clinical diagnosis and treatment. This evidence concerns the gene LINC00857 and pancreatic adenocarcinoma.